Clinical Trials in San Francisco

Showing 3121-3140 of 6,211 trials

Emtricitabine/Tenofovir Disoproxil Fumarate for HIV Prevention in Men

NCT00458393

The purpose of this study is to determine whether daily use of emtricitabine/tenofovir disoproxil fumarate (FTC/TDF) can prevent HIV infection in men who also receive HIV counseling, condoms, and treatment for other sexually transmitted infections (STIs).

HIV Infections

National Institute of Allergy and Infectious Diseases (NIAID)2,499 participantsStarted Jun 2007

San Francisco, California, United States • Chicago, Illinois, United States • Boston, Massachusetts, United States +8 more locations

COMPLETEDPhase 2< 1 mile

Safety and Effectiveness of the Oral HIV Entry Inhibitor Vicriviroc in HIV Infected Patients

NCT00082498

New treatment options are critical for treatment-experienced HIV infected patients with drug resistance. HIV entry inhibitors have been shown effective in patients with resistance to other anti-HIV drugs. This study will test the safety and effectiveness of three different doses of vicriviroc (formerly known as Schering D, SCH-D, or SCH 417690) in HIV infected patients.

HIV Infections

National Institute of Allergy and Infectious Diseases (NIAID)119 participantsStarted May 2004

Los Angeles, California, United States • Palo Alto, California, United States • San Diego, California, United States +27 more locations

Emtricitabine/Tenofovir Disoproxil Fumarate for HIV Prevention in Men

Safety and Effectiveness of the Oral HIV Entry Inhibitor Vicriviroc in HIV Infected Patients

Find Trials by Condition in San Francisco

Interleukin-2 Plus Anti-HIV Therapy in HIV-Infected Children With Weakened Immune Systems

A Study of Megestrol Acetate Alone or in Combination With Testosterone Enanthate Drug in the Treatment of HIV-Associated Weight Loss

Testosterone for HIV-Positive Men With Reduced Serum Testosterone Levels and Abdominal Fat

Dual Versus Triple Protease Inhibitor Combinations, Including Ritonavir, in HIV Infected People

A Comparison of Adefovir and Tenofovir for the Treatment of Lamivudine-Resistant Hepatitis B Virus in People With HIV

Acute Myeloid Leukemia T Cell Depletion to Improve Transplants in Adults With Acute Myeloid Leukemia (BMT CTN 0303)

BRAF/MEK/EGFR Inhibitor Combination Study in Colorectal Cancer (CRC)

A Study to Evaluate the Effects of Interleukin-12 (rhIL-12) in HIV-Positive Patients With CD4 Cell Counts Less Than 50 Cells/mm3 or 300-500 Cells/mm3

A Study to Evaluate the Effect of Nandrolone Decanoate in Women With HIV-Associated Weight Loss

A Study of the Safety and Effectiveness of Benralizumab to Treat Patients With Severe Uncontrolled Asthma.

Drug Interactions of Amprenavir and Efavirenz, in Combination With a Second Protease Inhibitor, in HIV-Negative Volunteers

Comparison of Two Methods in the Treatment of Cytomegalovirus of the Eyes in Patients With AIDS

Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis

The Safety and Efficacy of OPC-64005 in the Treatment of Adult Attention-deficit/Hyperactivity Disorder

A Study to Evaluate Steroid-free Treatment for Standard-Risk aGVHD (BMT CTN 1501)

Safety of and Immune Response to a DNA HIV Vaccine (VRC-HIVDNA009-00-VP) in HIV Infected Individuals With Acute HIV Infection

A Study to Test the Safety of Three Experimental HIV Vaccines

A Study to Evaluate the Ability of TNFR:Fc to Decrease the Amount of IL-6 (Interleukin-6) and TNF-alpha (Tumor Necrosis Factor) in HIV-Infected Patients